文献速递放疗物理与技术姑息放疗与转移瘤

双链断裂诱导与动力学显示角质形成细胞在7周放疗亚治疗剂量下超敏反应保留

Double strand break induction and kinetics indicate preserved hypersensitivity in keratinocytes to subtherapeutic doses for 7weeks of radiotherapy.
PubMed 文献 · Radiother Oncol · 2016-12-22

该研究对42例前列腺癌患者进行为期7周、每日0.05–1.10 Gy的皮肤剂量照射,通过γH2AX和53BP1标记的DSB焦点评估角质形成细胞的超敏反应(HRS)。结果显示HRS在整个治疗过程中持续存在,且24小时焦点提示明显的DSB持续,5次连续照射后焦点显著累积,低于0.3 Gy时72小时仍可见持续焦点。

要点

  • 7周分次放疗中亚治疗剂量下角质形成细胞的HRS持续存在。
  • 24小时焦点提示DSB持续,5次连续照射后焦点显著累积。
  • 低于0.3 Gy时,72小时仍可观察到持续焦点。

核心结论

  • 通过γH2AX和53BP1标记的DSB焦点评估,首次证明在7周每日重复亚治疗剂量分次治疗过程中HRS保留。

研究设计与样本

  • 42例前列腺癌患者接受7周分次放疗,每日皮肤剂量0.05–1.10 Gy。
  • 放疗前及治疗期间多个时间点收集皮肤活检共452份,于照射后30分钟及2、3、24、72小时采集。
  • 采用免疫荧光和免疫组化标记γH2AX和53BP1,数字图像分析与手动计数焦点。

主要发现

  • 角质形成细胞的HRS通过DSB焦点剂量-反应关系证实,在整个治疗过程中均可观察到,与采样时间和定量方法无关。
  • 照射后24小时观察到的焦点提示显著的DSB持续,5次连续剂量分次后焦点显著累积。
  • 对于低于0.3 Gy的剂量,损伤诱导后72小时仍可观察到持续焦点。
  • 双染活检中γH2AX和53BP1定量比较显示相似的HRS剂量-反应关系。

关键数值与推荐

  • 每日皮肤剂量分次为0.05–1.10 Gy,持续7周。
  • 低于0.3 Gy时,72小时仍可见持续焦点。

临床怎么用

  • 提示亚治疗剂量分次放疗期间角质形成细胞HRS持续存在,或可影响皮肤反应评估。
  • DSB焦点持续和累积现象需在临床放疗皮肤毒性监测中加以考虑。

局限性

  • 研究仅纳入前列腺癌患者皮肤活检,未提及其他肿瘤类型或部位。
  • 原文未报告样本量之外的统计效能或混杂因素控制细节。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Previously we reported that hyper-radiosensitivity (HRS) was evidenced by quantifying DNA double strand break (DSB) foci in epidermis biopsies collected after delivering radiotherapeutic one and five dose fractions. The aim of this study was to determine whether HRS was preserved throughout a 7-week radiotherapy treatment, and also to examine the rate of foci decline and foci persistence between dose fractions. MATERIALS AND METHODS: 42 patients with prostate cancer received 7-week fractionated radiotherapy treatment (RT) with daily dose fractions of 0.05-1.10Gy to the skin. Before RT, and at several times throughout treatment, skin biopsies (n=452) were collected at 30min, and 2, 3, 24, and 72h after dose fractions. DSB-foci markers, γH2AX and 53BP1, were labelled in epidermal keratinocytes with immunofluorescence and immunohistochemical staining. Foci were counted both with digital image analysis and manually. RESULTS: HRS in keratinocytes was evidenced by the dose-response relationships of DSB foci, observed throughout the treatment course, independent of sampling time and quantification method. Foci observed at 24h after dose fractions indicated considerable DSB persistence. Accordingly, foci significantly accumulated after 5 consecutive dose fractions. For doses below 0.3Gy, persistent foci could be observed even at 72h after damage induction. A comparison of γH2AX and 53BP1 quantifications in double-stained biopsies showed similar HRS dose-response relationships. CONCLUSIONS: These results represented the first evidence of preserved HRS, assessed by γH2AX- and 53BP1-labelled DSB foci, throughout a 7-week treatment course with daily repeated subtherapeutic dose fractions.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Qvarnström F, Simonsson M, Nyman J, et al. Double strand break induction and kinetics indicate preserved hypersensitivity in keratinocytes to subtherapeutic doses for 7weeks of radiotherapy. Radiother Oncol. 2016. PMID: 28017476. doi:10.1016/j.radonc.2016.12.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。